APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Hemorrhoid Cream and Injector

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Hemorrhoid Cream and Injector Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173997590328 December 2025192 pages

Choose your research edition.

Industry ResearchHemorrhoid Cream and Injector Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Hemorrhoid Cream and Injector Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Hemorrhoid Cream and Injector Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hemorrhoid Cream and Injector Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Hemorrhoid Cream and Injector Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Hemorrhoid Cream and Injector market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Hemorrhoid Cream and Injector is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Hemorrhoid Cream and Injector is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Hemorrhoid Cream and Injector is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Hemorrhoid Cream and Injector is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Hemorrhoid Cream and Injector include Yunnan Baiyao Group, Xiuzheng Pharmaceutical Group, Takeda Pharmaceutical, Mayinglong Pharmaceutical Group, Tucks, Sun Pharma, Prestige Consumer Healthcare, Naticura and Medline Industries, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Hemorrhoid Cream and Injector market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Hemorrhoid Cream and Injector and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hemorrhoid Cream and Injector sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hemorrhoid Cream and Injector market size, projected growth trends, production technologies, key applications, and end-use industries.

Hemorrhoid Cream and Injector Segment by Company

Yunnan Baiyao Group

Xiuzheng Pharmaceutical Group

Takeda Pharmaceutical

Mayinglong Pharmaceutical Group

Tucks

Sun Pharma

Prestige Consumer Healthcare

Naticura

Medline Industries

Ferndale Healthcare

eXroid

Doctor Bulter’s

Church and Dwight

Bausch Health

AdvaCare Pharma

Hemorrhoid Cream and Injector Segment by Type

Prescription Drug

Over-The-Counter Drug

Hemorrhoid Cream and Injector Segment by Application

Hospital

Household Use

Others

Hemorrhoid Cream and Injector Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hemorrhoid Cream and Injector market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hemorrhoid Cream and Injector and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hemorrhoid Cream and Injector.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Hemorrhoid Cream and Injector market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hemorrhoid Cream and Injector manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Hemorrhoid Cream and Injector in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Hemorrhoid Cream and Injector in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Hemorrhoid Cream and Injector Industry Trends Table 2. Hemorrhoid Cream and Injector Industry Drivers Table 3. Hemorrhoid Cream and Injector Industry Opportunities and Challenges Table 4. Hemorrhoid Cream and Injector Industry Restraints Table 5. Global Hemorrhoid Cream and Injector Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Hemorrhoid Cream and Injector Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Hemorrhoid Cream and Injector Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Hemorrhoid Cream and Injector Sales Market Share by Manufacturers Table 9. Global Hemorrhoid Cream and Injector Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Hemorrhoid Cream and Injector Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Hemorrhoid Cream and Injector Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Hemorrhoid Cream and Injector Manufacturers, Product Type & Application Table 13. Global Hemorrhoid Cream and Injector Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Hemorrhoid Cream and Injector by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Prescription Drug Table 17. Major Manufacturers of Over-The-Counter Drug Table 18. Global Hemorrhoid Cream and Injector Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Hemorrhoid Cream and Injector Sales by Type (2021-2026) & (K Units) Table 20. Global Hemorrhoid Cream and Injector Sales by Type (2027-2032) & (K Units) Table 21. Global Hemorrhoid Cream and Injector Sales Market Share by Type (2021-2026) Table 22. Global Hemorrhoid Cream and Injector Sales Market Share by Type (2027-2032) Table 23. Global Hemorrhoid Cream and Injector Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Hemorrhoid Cream and Injector Revenue by Type (2021-2026) & (K Units) Table 25. Global Hemorrhoid Cream and Injector Revenue by Type (2027-2032) & (K Units) Table 26. Global Hemorrhoid Cream and Injector Revenue Market Share by Type (2021-2026) Table 27. Global Hemorrhoid Cream and Injector Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Household Use Table 30. Major Manufacturers of Others Table 31. Global Hemorrhoid Cream and Injector Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Hemorrhoid Cream and Injector Sales by Application (2021-2026) & (K Units) Table 33. Global Hemorrhoid Cream and Injector Sales by Application (2027-2032) & (K Units) Table 34. Global Hemorrhoid Cream and Injector Sales Market Share by Application (2021-2026) Table 35. Global Hemorrhoid Cream and Injector Sales Market Share by Application (2027-2032) Table 36. Global Hemorrhoid Cream and Injector Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Hemorrhoid Cream and Injector Revenue by Application (2021-2026) & (K Units) Table 38. Global Hemorrhoid Cream and Injector Revenue by Application (2027-2032) & (K Units) Table 39. Global Hemorrhoid Cream and Injector Revenue Market Share by Application (2021-2026) Table 40. Global Hemorrhoid Cream and Injector Revenue Market Share by Application (2027-2032) Table 41. Global Hemorrhoid Cream and Injector Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Hemorrhoid Cream and Injector Sales by Region (2021-2026) & (K Units) Table 43. Global Hemorrhoid Cream and Injector Sales Market Share by Region (2021-2026) Table 44. Global Hemorrhoid Cream and Injector Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Hemorrhoid Cream and Injector Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Hemorrhoid Cream and Injector Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Hemorrhoid Cream and Injector Sales by Country (2021-2026) & (K Units) Table 48. North America Hemorrhoid Cream and Injector Sales by Country (2027-2032) & (K Units) Table 49. Europe Hemorrhoid Cream and Injector Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Hemorrhoid Cream and Injector Sales by Country (2021-2026) & (K Units) Table 51. Europe Hemorrhoid Cream and Injector Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Hemorrhoid Cream and Injector Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Hemorrhoid Cream and Injector Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Hemorrhoid Cream and Injector Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Hemorrhoid Cream and Injector Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Hemorrhoid Cream and Injector Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Hemorrhoid Cream and Injector Sales by Country (2027-2032) & (K Units) Table 58. Global Hemorrhoid Cream and Injector Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Hemorrhoid Cream and Injector Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Hemorrhoid Cream and Injector Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Hemorrhoid Cream and Injector Revenue Market Share by Region (2021-2026) Table 62. Global Hemorrhoid Cream and Injector Revenue Market Share by Region (2027-2032) Table 63. Yunnan Baiyao Group Company Information Table 64. Yunnan Baiyao Group Business Overview Table 65. Yunnan Baiyao Group Hemorrhoid Cream and Injector Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Yunnan Baiyao Group Hemorrhoid Cream and Injector Product Portfolio Table 67. Yunnan Baiyao Group Recent Development Table 68. Xiuzheng Pharmaceutical Group Company Information Table 69. Xiuzheng Pharmaceutical Group Business Overview Table 70. Xiuzheng Pharmaceutical Group Hemorrhoid Cream and Injector Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Xiuzheng Pharmaceutical Group Hemorrhoid Cream and Injector Product Portfolio Table 72. Xiuzheng Pharmaceutical Group Recent Development Table 73. Takeda Pharmaceutical Company Information Table 74. Takeda Pharmaceutical Business Overview Table 75. Takeda Pharmaceutical Hemorrhoid Cream and Injector Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Takeda Pharmaceutical Hemorrhoid Cream and Injector Product Portfolio Table 77. Takeda Pharmaceutical Recent Development Table 78. Mayinglong Pharmaceutical Group Company Information Table 79. Mayinglong Pharmaceutical Group Business Overview Table 80. Mayinglong Pharmaceutical Group Hemorrhoid Cream and Injector Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Mayinglong Pharmaceutical Group Hemorrhoid Cream and Injector Product Portfolio Table 82. Mayinglong Pharmaceutical Group Recent Development Table 83. Tucks Company Information Table 84. Tucks Business Overview Table 85. Tucks Hemorrhoid Cream and Injector Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Tucks Hemorrhoid Cream and Injector Product Portfolio Table 87. Tucks Recent Development Table 88. Sun Pharma Company Information Table 89. Sun Pharma Business Overview Table 90. Sun Pharma Hemorrhoid Cream and Injector Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Sun Pharma Hemorrhoid Cream and Injector Product Portfolio Table 92. Sun Pharma Recent Development Table 93. Prestige Consumer Healthcare Company Information Table 94. Prestige Consumer Healthcare Business Overview Table 95. Prestige Consumer Healthcare Hemorrhoid Cream and Injector Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Prestige Consumer Healthcare Hemorrhoid Cream and Injector Product Portfolio Table 97. Prestige Consumer Healthcare Recent Development Table 98. Naticura Company Information Table 99. Naticura Business Overview Table 100. Naticura Hemorrhoid Cream and Injector Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Naticura Hemorrhoid Cream and Injector Product Portfolio Table 102. Naticura Recent Development Table 103. Medline Industries Company Information Table 104. Medline Industries Business Overview Table 105. Medline Industries Hemorrhoid Cream and Injector Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Medline Industries Hemorrhoid Cream and Injector Product Portfolio Table 107. Medline Industries Recent Development Table 108. Ferndale Healthcare Company Information Table 109. Ferndale Healthcare Business Overview Table 110. Ferndale Healthcare Hemorrhoid Cream and Injector Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Ferndale Healthcare Hemorrhoid Cream and Injector Product Portfolio Table 112. Ferndale Healthcare Recent Development Table 113. eXroid Company Information Table 114. eXroid Business Overview Table 115. eXroid Hemorrhoid Cream and Injector Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. eXroid Hemorrhoid Cream and Injector Product Portfolio Table 117. eXroid Recent Development Table 118. Doctor Bulter’s Company Information Table 119. Doctor Bulter’s Business Overview Table 120. Doctor Bulter’s Hemorrhoid Cream and Injector Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Doctor Bulter’s Hemorrhoid Cream and Injector Product Portfolio Table 122. Doctor Bulter’s Recent Development Table 123. Church and Dwight Company Information Table 124. Church and Dwight Business Overview Table 125. Church and Dwight Hemorrhoid Cream and Injector Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Church and Dwight Hemorrhoid Cream and Injector Product Portfolio Table 127. Church and Dwight Recent Development Table 128. Bausch Health Company Information Table 129. Bausch Health Business Overview Table 130. Bausch Health Hemorrhoid Cream and Injector Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Bausch Health Hemorrhoid Cream and Injector Product Portfolio Table 132. Bausch Health Recent Development Table 133. AdvaCare Pharma Company Information Table 134. AdvaCare Pharma Business Overview Table 135. AdvaCare Pharma Hemorrhoid Cream and Injector Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. AdvaCare Pharma Hemorrhoid Cream and Injector Product Portfolio Table 137. AdvaCare Pharma Recent Development Table 138. Key Raw Materials Table 139. Raw Materials Key Suppliers Table 140. Hemorrhoid Cream and Injector Distributors List Table 141. Hemorrhoid Cream and Injector Customers List Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Hemorrhoid Cream and Injector Product Image Figure 2. Global Hemorrhoid Cream and Injector Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hemorrhoid Cream and Injector Market Size (2021-2032) & (US$ Million) Figure 4. Global Hemorrhoid Cream and Injector Sales (2021-2032) & (K Units) Figure 5. Global Hemorrhoid Cream and Injector Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Hemorrhoid Cream and Injector Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Prescription Drug Image Figure 9. Over-The-Counter Drug Image Figure 10. Global Hemorrhoid Cream and Injector Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Hemorrhoid Cream and Injector Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Hemorrhoid Cream and Injector Sales Market Share by Type (2021-2032) Figure 13. Global Hemorrhoid Cream and Injector Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Hemorrhoid Cream and Injector Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Hemorrhoid Cream and Injector Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Household Use Image Figure 18. Others Image Figure 19. Global Hemorrhoid Cream and Injector Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Hemorrhoid Cream and Injector Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Hemorrhoid Cream and Injector Sales Market Share by Application (2021-2032) Figure 22. Global Hemorrhoid Cream and Injector Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Hemorrhoid Cream and Injector Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Hemorrhoid Cream and Injector Revenue Market Share by Application (2021-2032) Figure 25. North America Hemorrhoid Cream and Injector Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Hemorrhoid Cream and Injector Sales Market Share by Country (2021-2032) Figure 27. U.S. Hemorrhoid Cream and Injector Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Hemorrhoid Cream and Injector Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Hemorrhoid Cream and Injector Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Hemorrhoid Cream and Injector Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Hemorrhoid Cream and Injector Sales Market Share by Country (2021-2032) Figure 32. Germany Hemorrhoid Cream and Injector Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Hemorrhoid Cream and Injector Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Hemorrhoid Cream and Injector Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Hemorrhoid Cream and Injector Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Hemorrhoid Cream and Injector Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Hemorrhoid Cream and Injector Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Hemorrhoid Cream and Injector Sales Market Share by Country (2021-2032) Figure 39. China Hemorrhoid Cream and Injector Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Hemorrhoid Cream and Injector Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Hemorrhoid Cream and Injector Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Hemorrhoid Cream and Injector Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Hemorrhoid Cream and Injector Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Hemorrhoid Cream and Injector Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Hemorrhoid Cream and Injector Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Hemorrhoid Cream and Injector Sales Market Share by Country (2021-2032) Figure 47. Brazil Hemorrhoid Cream and Injector Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Hemorrhoid Cream and Injector Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Hemorrhoid Cream and Injector Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Hemorrhoid Cream and Injector Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Hemorrhoid Cream and Injector Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Hemorrhoid Cream and Injector Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Hemorrhoid Cream and Injector Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Hemorrhoid Cream and Injector Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Hemorrhoid Cream and Injector Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Hemorrhoid Cream and Injector Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Hemorrhoid Cream and Injector Revenue (2021-2032) & (US$ Million) Figure 58. North America Hemorrhoid Cream and Injector Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Hemorrhoid Cream and Injector Revenue (2021-2032) & (US$ Million) Figure 60. Europe Hemorrhoid Cream and Injector Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Hemorrhoid Cream and Injector Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Hemorrhoid Cream and Injector Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Hemorrhoid Cream and Injector Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Hemorrhoid Cream and Injector Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Hemorrhoid Cream and Injector Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Hemorrhoid Cream and Injector Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Prescription Drug
  • Over-The-Counter Drug
Applications
  • Hospital
  • Household Use
  • Others
Companies covered
  • Yunnan Baiyao Group
  • Xiuzheng Pharmaceutical Group
  • Takeda Pharmaceutical
  • Mayinglong Pharmaceutical Group
  • Tucks
  • Sun Pharma
  • Prestige Consumer Healthcare
  • Naticura
  • Medline Industries
  • Ferndale Healthcare
  • eXroid
  • Doctor Bulter’s
  • Church and Dwight
  • Bausch Health
  • AdvaCare Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Hemorrhoid Cream and Injector Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Hemorrhoid Cream and Injector Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Hemorrhoid Cream and Injector Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Hemorrhoid Cream and Injector Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Hemorrhoid Cream and Injector Market Dynamics
  1. 2.1 Hemorrhoid Cream and Injector Industry Trends
  2. 2.2 Hemorrhoid Cream and Injector Industry Drivers
  3. 2.3 Hemorrhoid Cream and Injector Industry Opportunities and Challenges
  4. 2.4 Hemorrhoid Cream and Injector Industry Restraints
3 Hemorrhoid Cream and Injector Market by Manufacturers
  1. 3.1 Global Hemorrhoid Cream and Injector Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Hemorrhoid Cream and Injector Sales by Manufacturers (2021-2026)
  3. 3.3 Global Hemorrhoid Cream and Injector Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Hemorrhoid Cream and Injector Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hemorrhoid Cream and Injector Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Hemorrhoid Cream and Injector Manufacturers, Product Type & Application
  7. 3.7 Global Hemorrhoid Cream and Injector Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hemorrhoid Cream and Injector Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hemorrhoid Cream and Injector Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hemorrhoid Cream and Injector Tier 1, Tier 2, and Tier 3
4 Hemorrhoid Cream and Injector Market by Type
  1. 4.1 Hemorrhoid Cream and Injector Type Introduction
  2. 4.1.1 Prescription Drug
  3. 4.1.2 Over-The-Counter Drug
  4. 4.2 Global Hemorrhoid Cream and Injector Sales by Type
  5. 4.2.1 Global Hemorrhoid Cream and Injector Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Hemorrhoid Cream and Injector Sales by Type (2021-2032)
  7. 4.2.3 Global Hemorrhoid Cream and Injector Sales Market Share by Type (2021-2032)
  8. 4.3 Global Hemorrhoid Cream and Injector Revenue by Type
  9. 4.3.1 Global Hemorrhoid Cream and Injector Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Hemorrhoid Cream and Injector Revenue by Type (2021-2032)
  11. 4.3.3 Global Hemorrhoid Cream and Injector Revenue Market Share by Type (2021-2032)
5 Hemorrhoid Cream and Injector Market by Application
  1. 5.1 Hemorrhoid Cream and Injector Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Household Use
  4. 5.1.3 Others
  5. 5.2 Global Hemorrhoid Cream and Injector Sales by Application
  6. 5.2.1 Global Hemorrhoid Cream and Injector Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Hemorrhoid Cream and Injector Sales by Application (2021-2032)
  8. 5.2.3 Global Hemorrhoid Cream and Injector Sales Market Share by Application (2021-2032)
  9. 5.3 Global Hemorrhoid Cream and Injector Revenue by Application
  10. 5.3.1 Global Hemorrhoid Cream and Injector Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Hemorrhoid Cream and Injector Revenue by Application (2021-2032)
  12. 5.3.3 Global Hemorrhoid Cream and Injector Revenue Market Share by Application (2021-2032)
6 Global Hemorrhoid Cream and Injector Sales by Region
  1. 6.1 Global Hemorrhoid Cream and Injector Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Hemorrhoid Cream and Injector Sales by Region (2021-2032)
  3. 6.2.1 Global Hemorrhoid Cream and Injector Sales by Region (2021-2026)
  4. 6.2.2 Global Hemorrhoid Cream and Injector Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Hemorrhoid Cream and Injector Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Hemorrhoid Cream and Injector Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Hemorrhoid Cream and Injector Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Hemorrhoid Cream and Injector Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Hemorrhoid Cream and Injector Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Hemorrhoid Cream and Injector Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Hemorrhoid Cream and Injector Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Hemorrhoid Cream and Injector Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Hemorrhoid Cream and Injector Revenue by Region
  1. 7.1 Global Hemorrhoid Cream and Injector Revenue by Region
  2. 7.1.1 Global Hemorrhoid Cream and Injector Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Hemorrhoid Cream and Injector Revenue by Region (2021-2026)
  4. 7.1.3 Global Hemorrhoid Cream and Injector Revenue by Region (2027-2032)
  5. 7.1.4 Global Hemorrhoid Cream and Injector Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Hemorrhoid Cream and Injector Revenue (2021-2032)
  8. 7.2.2 North America Hemorrhoid Cream and Injector Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Hemorrhoid Cream and Injector Revenue (2021-2032)
  11. 7.3.2 Europe Hemorrhoid Cream and Injector Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Hemorrhoid Cream and Injector Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Hemorrhoid Cream and Injector Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Hemorrhoid Cream and Injector Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Hemorrhoid Cream and Injector Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Yunnan Baiyao Group
  2. 8.1.1 Yunnan Baiyao Group Company Information
  3. 8.1.2 Yunnan Baiyao Group Business Overview
  4. 8.1.3 Yunnan Baiyao Group Hemorrhoid Cream and Injector Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Yunnan Baiyao Group Hemorrhoid Cream and Injector Product Portfolio
  6. 8.1.5 Yunnan Baiyao Group Recent Developments
  7. 8.2 Xiuzheng Pharmaceutical Group
  8. 8.2.1 Xiuzheng Pharmaceutical Group Company Information
  9. 8.2.2 Xiuzheng Pharmaceutical Group Business Overview
  10. 8.2.3 Xiuzheng Pharmaceutical Group Hemorrhoid Cream and Injector Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Xiuzheng Pharmaceutical Group Hemorrhoid Cream and Injector Product Portfolio
  12. 8.2.5 Xiuzheng Pharmaceutical Group Recent Developments
  13. 8.3 Takeda Pharmaceutical
  14. 8.3.1 Takeda Pharmaceutical Company Information
  15. 8.3.2 Takeda Pharmaceutical Business Overview
  16. 8.3.3 Takeda Pharmaceutical Hemorrhoid Cream and Injector Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Takeda Pharmaceutical Hemorrhoid Cream and Injector Product Portfolio
  18. 8.3.5 Takeda Pharmaceutical Recent Developments
  19. 8.4 Mayinglong Pharmaceutical Group
  20. 8.4.1 Mayinglong Pharmaceutical Group Company Information
  21. 8.4.2 Mayinglong Pharmaceutical Group Business Overview
  22. 8.4.3 Mayinglong Pharmaceutical Group Hemorrhoid Cream and Injector Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Mayinglong Pharmaceutical Group Hemorrhoid Cream and Injector Product Portfolio
  24. 8.4.5 Mayinglong Pharmaceutical Group Recent Developments
  25. 8.5 Tucks
  26. 8.5.1 Tucks Company Information
  27. 8.5.2 Tucks Business Overview
  28. 8.5.3 Tucks Hemorrhoid Cream and Injector Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Tucks Hemorrhoid Cream and Injector Product Portfolio
  30. 8.5.5 Tucks Recent Developments
  31. 8.6 Sun Pharma
  32. 8.6.1 Sun Pharma Company Information
  33. 8.6.2 Sun Pharma Business Overview
  34. 8.6.3 Sun Pharma Hemorrhoid Cream and Injector Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sun Pharma Hemorrhoid Cream and Injector Product Portfolio
  36. 8.6.5 Sun Pharma Recent Developments
  37. 8.7 Prestige Consumer Healthcare
  38. 8.7.1 Prestige Consumer Healthcare Company Information
  39. 8.7.2 Prestige Consumer Healthcare Business Overview
  40. 8.7.3 Prestige Consumer Healthcare Hemorrhoid Cream and Injector Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Prestige Consumer Healthcare Hemorrhoid Cream and Injector Product Portfolio
  42. 8.7.5 Prestige Consumer Healthcare Recent Developments
  43. 8.8 Naticura
  44. 8.8.1 Naticura Company Information
  45. 8.8.2 Naticura Business Overview
  46. 8.8.3 Naticura Hemorrhoid Cream and Injector Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Naticura Hemorrhoid Cream and Injector Product Portfolio
  48. 8.8.5 Naticura Recent Developments
  49. 8.9 Medline Industries
  50. 8.9.1 Medline Industries Company Information
  51. 8.9.2 Medline Industries Business Overview
  52. 8.9.3 Medline Industries Hemorrhoid Cream and Injector Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Medline Industries Hemorrhoid Cream and Injector Product Portfolio
  54. 8.9.5 Medline Industries Recent Developments
  55. 8.10 Ferndale Healthcare
  56. 8.10.1 Ferndale Healthcare Company Information
  57. 8.10.2 Ferndale Healthcare Business Overview
  58. 8.10.3 Ferndale Healthcare Hemorrhoid Cream and Injector Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Ferndale Healthcare Hemorrhoid Cream and Injector Product Portfolio
  60. 8.10.5 Ferndale Healthcare Recent Developments
  61. 8.11 eXroid
  62. 8.11.1 eXroid Company Information
  63. 8.11.2 eXroid Business Overview
  64. 8.11.3 eXroid Hemorrhoid Cream and Injector Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 eXroid Hemorrhoid Cream and Injector Product Portfolio
  66. 8.11.5 eXroid Recent Developments
  67. 8.12 Doctor Bulter’s
  68. 8.12.1 Doctor Bulter’s Company Information
  69. 8.12.2 Doctor Bulter’s Business Overview
  70. 8.12.3 Doctor Bulter’s Hemorrhoid Cream and Injector Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Doctor Bulter’s Hemorrhoid Cream and Injector Product Portfolio
  72. 8.12.5 Doctor Bulter’s Recent Developments
  73. 8.13 Church and Dwight
  74. 8.13.1 Church and Dwight Company Information
  75. 8.13.2 Church and Dwight Business Overview
  76. 8.13.3 Church and Dwight Hemorrhoid Cream and Injector Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Church and Dwight Hemorrhoid Cream and Injector Product Portfolio
  78. 8.13.5 Church and Dwight Recent Developments
  79. 8.14 Bausch Health
  80. 8.14.1 Bausch Health Company Information
  81. 8.14.2 Bausch Health Business Overview
  82. 8.14.3 Bausch Health Hemorrhoid Cream and Injector Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Bausch Health Hemorrhoid Cream and Injector Product Portfolio
  84. 8.14.5 Bausch Health Recent Developments
  85. 8.15 AdvaCare Pharma
  86. 8.15.1 AdvaCare Pharma Company Information
  87. 8.15.2 AdvaCare Pharma Business Overview
  88. 8.15.3 AdvaCare Pharma Hemorrhoid Cream and Injector Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 AdvaCare Pharma Hemorrhoid Cream and Injector Product Portfolio
  90. 8.15.5 AdvaCare Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Hemorrhoid Cream and Injector Value Chain Analysis
  2. 9.1.1 Hemorrhoid Cream and Injector Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Hemorrhoid Cream and Injector Production Mode & Process
  6. 9.2 Hemorrhoid Cream and Injector Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Hemorrhoid Cream and Injector Distributors
  9. 9.2.3 Hemorrhoid Cream and Injector Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst